Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Jane T. Osterhaus"'
Autor:
Jane T. Osterhaus, Jean Paul Gagnon
Publikováno v:
Annals of Pharmacotherapy. 40:524-528
The advent of prospective reimbursement in hospitals has forced hospital administrators, pharmacy directors, and pharmacy and therapeutic committees to carefully compare the cost and benefits of similar drugs. Accomplishing this task is difficult. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4487691313a65aff0bd16f46d7debfd2
https://doi.org/10.1345/aph.140010
https://doi.org/10.1345/aph.140010
Autor:
Andrew Whelton, Susan Bristol, Corey May, Thomas A. Burke, Jane T. Osterhaus, Chuck Wentworth
Publikováno v:
Clinical Therapeutics. 24:969-989
Background: The addition of a nonsteroidal anti-inflammatory drug to the regimen of a patient with treated hypertension can cause a destabilization of blood pressure. Objective: The aim of this study was to describe physician-reported management of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e164a55302e502c342101e5ad9534f98
https://doi.org/10.1016/s0149-2918(02)80011-x
https://doi.org/10.1016/s0149-2918(02)80011-x
Autor:
Patty Kumbera, Michael E. Ernst, Jane T. Osterhaus, Matthew C. Osterhaus, Seema D. Dedhiya, William R. Doucette, Raymond J. Townsend
Publikováno v:
Pharmacotherapy. 21:988-997
Study Objective. To determine whether community pharmacists can use point-of-service health status assessments to identify and resolve drug-related problems (DRPs) in ambulatory patients with selected musculoskeletal (MSK) disorders. Design. Twelve-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b94b05cf5b40338f3bfbff01d08c23
https://doi.org/10.1592/phco.21.11.988.34525
https://doi.org/10.1592/phco.21.11.988.34525
Publikováno v:
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 56:M167-M175
Background. This study evaluates the impact of celecoxib on functional status, health-related quality of life (HRQOL), and safety of elderly patients ( $ 70 years) with osteoarthritis (OA) of the knee and/or hip. Methods. Data were pooled from three
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cfcc531208b28b9ca5ad73431f179a4
https://doi.org/10.1093/gerona/56.3.m167
https://doi.org/10.1093/gerona/56.3.m167
Autor:
Jane T Osterhaus, Oana Purcaru
Publikováno v:
Arthritis Research & Therapy
Introduction The arthritis-specific Work Productivity Survey (WPS) was developed to evaluate productivity limitations associated with arthritis within and outside the home. There is an unmet need for an instrument assessing similar productivity limit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0427616004c03fc6626a9e771d439dc
https://pubmed.ncbi.nlm.nih.gov/25099160
https://pubmed.ncbi.nlm.nih.gov/25099160
Publikováno v:
Arthritis & Rheumatism. 43:1478-1487
Objective To define clinically meaningful changes in 2 widely used health-related quality of life (HQL) instruments in studies of patients with rheumatoid arthritis (RA). Methods Patients with RA (n = 693) who were enrolled in 2 double-blind, placebo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ef7e09bf04d865c466bb01941105354
https://doi.org/10.1002/1529-0131(200007)43:7<1478::aid-anr10>3.0.co
https://doi.org/10.1002/1529-0131(200007)43:7<1478::aid-anr10>3.0.co
Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib
Autor:
Justus I. Fiechtner, Shawn S. Yu, Seema D. Dedhiya, William W. Zhao, Jane T. Osterhaus, Sean Z. Zhao, Elizabeth A. Tindall
Publikováno v:
Arthritis & Rheumatism. 13:112-121
Objective To study the functional status and health-related quality of life (HRQOL) of patients with rheumatoid arthritis (RA) after treatment with celecoxib, compared with placebo and naproxen. Methods This was a prospective, randomized, double-blin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bbe7cd1277ea946701e83039455271a
https://doi.org/10.1002/1529-0131(200004)13:2<112::aid-anr5>3.0.co
https://doi.org/10.1002/1529-0131(200004)13:2<112::aid-anr5>3.0.co
Publikováno v:
Headache: The Journal of Head and Face Pain. 38:295-302
This paper describes the development and validation of a migraine-specific quality-of-life instrument that is capable of measuring health-related quality-of-life impairments attributed to migraine. Item selection, item reduction, and pretesting and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77feeeb4495f8099492eb25fc1f95236
https://doi.org/10.1046/j.1526-4610.1998.3804295.x
https://doi.org/10.1046/j.1526-4610.1998.3804295.x
Publikováno v:
Drug Information Journal. 30:185-193
A heartburn-specific quality of life instrument was developed using an approach which involves several steps: generating and selecting items, pretesting, reproducibility testing, and validity testing. These last two steps were performed in a randomiz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8d6838031a8866e338fd40182cf818a
https://doi.org/10.1177/009286159603000122
https://doi.org/10.1177/009286159603000122
Autor:
Faye A. Luscombe, Raymond J. Townsend, Josephine Mauskopf, Jane T. Osterhaus, Joel Bobula, Kevan Clemens
Publikováno v:
PharmacoEconomics. 8:169-174
In January 1995, the Pharmaceutical Research and Manufacturers of America (PhRMA) adopted a voluntary set of principles to provide guidance for its member companies on the conduct and evaluation of pharmacoeconomic research. The principles were prepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49a2bf9f7bdada4abf2ca40a5788304d
https://doi.org/10.2165/00019053-199508020-00008
https://doi.org/10.2165/00019053-199508020-00008